PDGF-BB Deficiency in the Blood Serum from Aplastic Anemia Patients Affects Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells
Cells · 2024-11-18 · 13 (22) · 1908
DOI: 10.3390/cells13221908 ↗At a glance
Journal article in Cells, published online on 2024-11-18. Written by Alena I Dorofeeva and 8 co-authors. Institution: National Medical Research Center for Hematology, Moscow 127167, Russia. Major MEDLINE topics: Anemia, Aplastic, Mesenchymal Stem Cells, Becaplermin, Cell Proliferation. Cited 3 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Aplastic anemia (AA) is characterized by bone marrow (BM) aplasia and pancytopenia. BM stromal microenvironment is closely intertwined with hematopoietic cells by reciprocal regulation. It is still unclear how hematopoietic deficiency affects the bone marrow stroma of the AA patients. Multipotent mesenchymal stromal cells (MMSCs) are the progenitors of stromal cells. In vitro, proliferation rate of MMSCs of AA patients is decreased compared to those of healthy donors. This may be explained by the influence of pathological environmental condition in the patients’ BM. The aim of the study was to compare the effect of AA patients’ sera on healthy donor MMSCs to healthy donors’ sera and to elucidate the nature of their difference. Proliferation test showed 3-fold decrease in number of MMSCs after incubation in medium supplemented with AA patients’ sera compared to donors’ serum samples. The degree of this effect correlated with the severity of thrombocytopenia in patients. The decrease in cell number was not associated with cell death, as the number of apoptotic cells defined by flow cytometry did not differ between the groups. ELISA revealed a decreased level of PDGF-BB in the patients’ sera compared to donors’ serum samples (69 ± 5 pg/mL vs. 112 ± 21 pg/mL, respectively). The addition of recombinant PDGF-BB or healthy donor’s platelet lysate to the culture medium supplemented with AA patients’ serum restored its ability to support MMSCs growth. Thus, PDGF-BB deficiency is one of the environmental factors causing MMSCs damage in AA patients.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- National Medical Research Center for Hematology, Moscow 127167, Russia.
ORCID profiles: Irina N Shipounova
Cite
APA
Dorofeeva, A. I., Shipounova, I. N., Nikiforova, K. A., Galtseva, I. V., Kuzmina, L. A., Luchkin, A. V., Fidarova, Z. T., Mikhailova, E. A., & Parovichnikova, E. N. (2024). PDGF-BB Deficiency in the Blood Serum from Aplastic Anemia Patients Affects Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells. Cells, 13(22), 1908. https://doi.org/10.3390/cells13221908
Vancouver
Dorofeeva AI, Shipounova IN, Nikiforova KA, Galtseva IV, Kuzmina LA, Luchkin AV, et al. PDGF-BB Deficiency in the Blood Serum from Aplastic Anemia Patients Affects Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells. Cells. 2024;13(22):1908. doi:10.3390/cells13221908
BibTeX
@article{Dorofeeva2024,
author = {Dorofeeva, Alena I and Shipounova, Irina N and Nikiforova, Ksenia A and Galtseva, Irina V and Kuzmina, Larisa A and Luchkin, Anton V and Fidarova, Zalina T and Mikhailova, Elena A and Parovichnikova, Elena N},
title = {PDGF-BB Deficiency in the Blood Serum from Aplastic Anemia Patients Affects Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells},
journal = {Cells},
year = {2024},
volume = {13},
number = {22},
pages = {1908},
doi = {10.3390/cells13221908}
}
EUVIMED